RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy

E-ISSN： 1873-4294|12|2|69-78

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.2, 2012-01, pp. : 69-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNA-Mediated Interference as a Tool for Identifying Drug Targets

By Oneil N.J. Martin R.L. Tomlinson M.L. Jones M.R. Coulson A. Kuwabara P.E.

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 45-53

Adis International

Access to resources Recommend Favorite

MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1566-1584

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for RNA Interference and their Application in Cancer Therapy

Current Pharmacogenomics, Vol. 2, Iss. 4, 2004-12 ,pp. : 313-324

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting survivin in cancer therapy

By Pennati Marzia Folini Marco Zaffaroni Nadia

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 463-476

Informa Healthcare

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite